Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study

Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study

BackgroundCurrent guidelines prioritize the use of Azvudine in Coronavirus Disease 2019 (COVID-19) patients, while biomarkers for prognosis in Azvudine-treated COVID-19 patients are still lacking. Here, we aim to assess the prognostic value of eosinopenia in Azvudine-treated COVID-19 patients.Method...

Descripció completa

Dades bibliogràfiques
Autors principals: Xiaomin Wang, Yating Dian, Qian Zhou, Guangtong Deng, Rui Wei, Furong Zeng
Format: Article
Idioma:English
Publicat: Frontiers Media S.A. 2023-12-01
Col·lecció:Frontiers in Immunology
Matèries:
COVID-19
eosinopenia
azvudine
prognosis
outcome
Accés en línia:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1320973/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1320973/full

Ítems similars